A 99mTc-Labeled Triphenylphosphonium Derivative for the Early Detection of Breast Tumors

Cancer Biotherapy and Radiopharmaceuticals

Volumn 24, Issue 5, 2009, Pages 579-587

  Li, Zhixin ^a   Lopez, Marcos ^a,b   Hardy, Micaël ^a,b   McAllister, Donna M ^a   Kalyanaraman, Balaraman ^a,b   Zhao, Ming ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b FREE RADICAL RESEARCH CENTER   (United States)

Author keywords

Breast cancer; DMBA; Mitochondria; Scintimammography

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; RADIOISOTOPE; TECHNETIUM TRIPHENYLPHOSPHONIUM TC 99M; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST TUMOR; CANCER DIAGNOSIS; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG SYNTHESIS; EARLY DIAGNOSIS; FEMALE; HISTOPATHOLOGY; ISOTOPE LABELING; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; RAT; TISSUE DISTRIBUTION;

ANIMALS; BREAST NEOPLASMS; DISEASE MODELS, ANIMAL; EARLY DETECTION OF CANCER; FEMALE; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; MODELS, CHEMICAL; NEOPLASM TRANSPLANTATION; RADIOPHARMACEUTICALS; RATS; RATS, SPRAGUE-DAWLEY; TECHNETIUM; TECHNETIUM TC 99M SESTAMIBI;

EID: 70449135470     PISSN: 10849785     EISSN: None     Source Type: Journal    
DOI: 10.1089/cbr.2008.0606     Document Type: Article

References (23)

1. Parker S, Tong T, Bolden S, et al. Cancer statistics. CA Cancer J Clin 1997; 47:5.
2. Jemal A, Tiwari RC, Murray T, et al. Cancer statistics. CA Cancer J Clin 2004; 54:8.
3. Yang MD, Sun SS, Kao CH, et al. Usefulness of technetium- 99m tetrofosmin scintimammography to detect breast cancer in mammographically dense breasts. Cancer Invest 2002; 20:518.
4. Khalkhali I, Baum JK, Villanueva-Meyer J, et al. 99mTcsestamibi breast imaging for the examination of patients with dense and fatty breasts: Multicenter study. Radiology 2002; 222:149.
5. Khalkhali I, Cutrone JA, Mena I. Scintimammography: The complementary role of Tc-99m-sestamibi prone breast imaging for the diagnosis of breast carcinoma. Radiology 1995; 196:421.
6. Hussain R, Buscombe JR. A meta-analysis of scintimammography: An evidence-based approach to its clinical utility. Nucl Med Comm 2006; 27:589.
7. Mathieu I, Mazy S, Willemart B, et al. Inconclusive triple diagnosis in breast cancer imaging: Is there a place for scintimmography? J Nucl Med 2005; 46:1574.
8. Schillaci O, Buscombe JR. Breast scintigraphy today: Indications and limitations. Eur J Nucl Med Mol Imaging 2004; 31:S35.
9. Carvalho PA, Chiu ML, Kronauge JF, et al. Subcellular distribution and analysis of Tc-99m-MIBI in isolated perfused rat hearts. J Nucl Med 1992; 33:1516.
10. Delmon-Mongeon LI, Piwinica-Worms D, Van der Abbeele AD, et al. Uptake of the cation hexakis (2-methoxyisobutylisonitrile)- technetium-99m by human carcinoma cell lines in vitro. Cancer Res 1990; 50:2198.
11. Scopinaro F, Schillaci O, Scarpini M, et al. Technetium-99msestamibi: An indicator of breast cancer invasiveness. Eur J Nucl Med 1994; 21:984.
12. Kroemer G. Mitochondria in cancer. Oncogene 2006; 25: 4630.
13. Ross MF, Kelso GF, Blaikie FH, et al. Lipophilic triphenylphosphonium cations as tools in mitochondrial bioenergetics and free radical biology. Biochemistry 2005; 70:222.
14. Manetta A, Gamboa G, Nasseri A, et al. Novel phosphonium salts display in vitro and in vivo cytotoxic activity against human ovarian cancer cell lines. Gynecol Oncol 1996; 60:203.
15. Smith RAJ, Kelso GF, James AM, et al. Targeting coenzyme Q derivatives to mitochondria. Meth Enzymol 2004; 382:45.
16. Sheu SS, Nauduri D, Anders MW. Targeting antioxidants to mitochondria: A new therapeutic direction. Bioc Bioph Acta 2006; 1762:256.
17. Wang Y, Liu X, Hnatowich DJ. An improved synthesis of NHS-MAG3 for conjugation and radiolabeling of biomolecules with (99m)Tc at room temperature. Nat Protoc 2007; 2:972.
18. Pwnica-Worms D, Chiu ML, Budding M, et al. Functional imaging of multidrug-resistant P-glycoprotein with an organotechnetium complex. Cancer Res 1993; 53:977.
19. Thompson HJ, Singh M. Rat models of premalignant breast disease. J Mammary Gland Biol Neoplasia 2000; 5:409.
20. Jordan VC. Laboratory models of breast cancer to aid the elucidation of antiestrogen action. J Lab Clin Med 1987; 109:267.
21. Nandi S, Guzman R C, Yang J. Hormones and mammary carcinogenesis in mice, rats, and humans: A unifying hypothesis. Proc Natl Acad Sci U S A 1995; 92:3650.
22. Wang J, Yang CT, Kim YS, et al. 64Cu-labeled triphenylphosphonium and triphenylarsonium cations as highly tumor- selective imaging agents. J Med Chem 2007; 50:5057.
23. Kim YS, Yang CT, Wang J, et al. Effects of targeting moiety, linker, bifunctional chelator, and molecular charge on biological properties of (64)cu-labeled triphenylphosphonium cations. J Med Chem 2008; 51:2971.